forums

Forums
Each WNYVA forum features presentations by two companies that are seeking private equity investment.

Presenters are pre-screened and are some of the up-and-coming businesses in our region. Our forums also present the opportunity to network with angel investors, venture capital firms and other business professionals. Non-members are welcome.

Next Forum: Wednesday, June 11, 2008

The Buffalo Club, 388 Delaware Avenue, Buffalo, NY (Business Attire Required)

Cost (includes continental breakfast):
Members and 1st time guests of members – Free
Non-members - $20.00

RSVP: Jack McGowan or Sandie Wade at 636-3626 or info@wnyventure.com

Program: 7:30 - 8:00 AM Registration, Continental Breakfast, Informal Networking

8:00 - 8:10 AM Attendee Self-Introductions
8:10 - 9:00 AM Business Plan Presentations and Audience Critique

Presenters:

SensiVida Medical Systems, Inc. - Kamal Sarbadhikari, CEO

SensiVida Medical Systems, a spin-off of Infotonics Technology Center, a NY State Center of Excellence, is a minimally invasive diagnostic device company. Their proprietary Micro-systems based technology automates bio-sensing and electronic data acquisition while minimizing patient discomfort. While the platform technology (9 patents filed) can address a number of disease state diagnostics – Allergy Testing, pain-free Glucose monitoring, blood Coagulation Testing, Cholesterol monitoring, and TB Testing – the Company’s singular focus is to commercialize a digital Allergy Test that is pain-free and 2X as productive.

The US allergy test market is estimated to be $1.5B ($3.2B worldwide). In the US, 6 million skin prick/scratch tests are done each year, growing at 7% CAGR. These tests are manual, subjective and invasive, especially for children. The SensiVida test will improve the Allergists’ profitability by 25% by improving cycle time by 2X and creating digital electronic medical records, eliminating today’s subjective, time-consuming testing. Over time, SensiVida’s allergy test will become available at US Retail Clinics as a screening test targeting the needs of 32M patients that are currently undiagnosed.

SensiVida’s allergy testing system consists of (1) a disposable micro-lancet chip/cartridge that painlessly and rapidly administers the allergens, (2) a compact imaging module/digital imager (provided at no cost) that captures real-time allergic reactions and sends images to a computer and (3) user-friendly software that allows the user to monitor the allergic reaction. An e-record patient report is automatically created which can be printed or transmitted.

SensiVida seeks $800 K of equity funding needed to develop opto-electronic systems, algorithm and to conduct 100 patient clinical trials.

SocialVoter, LLC - Michael Falencki, CEO

SocialVoter will become a full-service, one-stop provider for political content and user interaction on the web. SocialVoter is being created to attract users seeking to view or engage in a community focused on social and political issues. The community will have all the attributes of popular social networks, and in addition, will raise user interest through social issue and political news, voting records, politician biographies, and campaign contribution history.

Through SocialVoter, not only will users have the ability to directly interact with politicians and their campaigns, but the community will also allow them to communicate with like-minded people and debate with people of differing viewpoints, while discussing the social and political issues that matter to them most.

In the same way that the Internet has changed the way the world communicates, SocialVoter will change the way politicians and voters interact with each other. Most importantly, the community provides a means for voters to have a voice in defining social and political issues that supports one of the principles by which our country was initially formed – a government “of the people, by the people, and for the people”. SocialVoter – Your issues. Your Voice. Your impact.

SocialVoter, LLC is looking for $1 million to cover development costs and staffing requirements. An unfunded Beta version of SocialVoter is already under development.

Western New York Venture Association
726 Exchange St., Suite 620 | Buffalo, NY 14210
Phone: 716-636-3626 Fax: 716-845-6418
E-mail: info@wnyventure.com